SSWM
CVS icon

Sheets Smith Wealth Management’s CVS Health CVS Stock Holding History

Sheets Smith Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Sell
2,214
-6,997
-76% -$625K 0.02% 381
2026
Q1 		$662K Sell
9,211
-7,845
-46% -$604K 0.07% 246
2025
Q4 		$1.35M Buy
17,056
+83
+0.5% +$6.54K 0.15% 141
2025
Q3 		$1.28M Buy
16,973
+11,350
+202% +$778K 0.14% 143
2025
Q2 		$388K Sell
5,623
-11,800
-68% -$774K 0.05% 315
2025
Q1 		$1.18M Sell
17,423
-2,186
-11% -$131K 0.15% 139
2024
Q4 		$880K Sell
19,609
-11,620
-37% -$652K 0.11% 172
2024
Q3 		$1.96M Sell
31,229
-76,287
-71% -$4.45M 0.24% 100
2024
Q2 		$6.35M Sell
107,516
-9,768
-8% -$611K 0.76% 31
2024
Q1 		$9.35M Buy
117,284
+9,983
+9% +$763K 1.05% 21
2023
Q4 		$8.47M Buy
107,301
+43,426
+68% +$3.09M 1.21% 23
2023
Q3 		$4.46M Buy
63,875
+6,009
+10% +$426K 0.68% 37
2023
Q2 		$4M Buy
57,866
+45,108
+354% +$3.21M 0.58% 43
2023
Q1 		$948K Sell
12,758
-23
-0.2% -$1.93K 0.14% 135
2022
Q4 		$1.19M Sell
12,781
-363
-3% -$35K 0.19% 115
2022
Q3 		$1.25M Buy
13,144
+2,463
+23% +$244K 0.21% 108
2022
Q2 		$990K Sell
10,681
-4,002
-27% -$391K 0.16% 127
2022
Q1 		$1.49M Sell
14,683
-255
-2% -$26.8K 0.2% 107
2021
Q4 		$1.54M Buy
14,938
+4
+0% +$370 0.19% 115
2021
Q3 		$1.27M Buy
14,934
+19
+0.1% +$1.59K 0.17% 128
2021
Q2 		$1.24M Sell
14,915
-749
-5% -$61.3K 0.17% 130
2021
Q1 		$1.18M Buy
15,664
+110
+0.7% +$8.01K 0.17% 130
2020
Q4 		$1.06M Buy
15,554
+803
+5% +$52.2K 0.16% 129
2020
Q3 		$861K Buy
14,751
+95
+0.6% +$5.91K 0.15% 127
2020
Q2 		$952K Buy
14,656
+8,869
+153% +$558K 0.19% 109
2020
Q1 		$343K Buy
5,787
+841
+17% +$56.1K 0.07% 191
2019
Q4 		$367K Buy
4,946
+249
+5% +$17.5K 0.07% 241
2019
Q3 		$296K Buy
4,697
+256
+6% +$15.2K 0.06% 251
2019
Q2 		$242K Buy
4,441
+636
+17% +$34.3K 0.05% 289
2019
Q1 		$205K Sell
3,805
-619
-14% -$38.2K 0.04% 303
2018
Q4 		$290K Sell
4,424
-2,175
-33% -$162K 0.08% 231
2018
Q3 		$519K Buy
+6,599
New +$472K 0.11% 210
2017
Q4 		– Sell
-9,310
Closed -$757K – 323
2017
Q3 		$757K Buy
9,310
+139
+2% +$11K 0.19% 143
2017
Q2 		$738K Buy
9,171
+55
+0.6% +$4.34K 0.2% 133
2017
Q1 		$716K Buy
9,116
+110
+1% +$8.78K 0.19% 144
2016
Q4 		$711K Sell
9,006
-1,496
-14% -$121K 0.2% 141
2016
Q3 		$935K Sell
10,502
-7,849
-43% -$741K 0.26% 106
2016
Q2 		$1.76M Buy
18,351
+8,060
+78% +$803K 0.51% 61
2016
Q1 		$1.07M Buy
10,291
+233
+2% +$22.7K 0.33% 78
2015
Q4 		$983K Buy
10,058
+157
+2% +$15.4K 0.3% 91
2015
Q3 		$955K Buy
9,901
+192
+2% +$20.2K 0.32% 85
2015
Q2 		$1.02M Buy
9,709
+92
+1% +$9.4K 0.28% 107
2015
Q1 		$993K Buy
9,617
+562
+6% +$56.9K 0.27% 110
2014
Q4 		$872K Buy
9,055
+5,549
+158% +$489K 0.23% 134
2014
Q3 		$279K Buy
+3,506
New +$276K 0.08% 198

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sheets Smith Wealth Management's CVS Position: Q2 2026 in Review

Sheets Smith Wealth Management reduced its CVS Health (CVS) stake by 76% in Q2 2026, selling an estimated $625K and leaving 2,214 shares worth $229K. The position accounts for 0.02% of the portfolio, ranked #381.

Sheets Smith Wealth Management first reported a position in CVS in Q3 2014 and has held it in 45 quarters since. The position peaked at $9.35M in Q1 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Sheets Smith Wealth Management held 2,214 shares of CVS Health worth $229K as of Q2 2026.
  • Sheets Smith Wealth Management sold 6,997 CVS Health shares in Q2 2026, an estimated $625K.
  • CVS Health made up 0.02% of Sheets Smith Wealth Management's portfolio in Q2 2026, its #381 holding.
  • Sheets Smith Wealth Management first reported a position in CVS Health in Q3 2014 and has held it in 45 quarters since.
  • Sheets Smith Wealth Management's CVS Health position peaked at $9.35M in Q1 2024.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Sheets Smith Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.